先天性簇状肠病肝脏病理及MOC31免疫组化表现
本文描述3例先天性簇状肠病(CTE)患者的4次肝活检病理,所有标本均显示胆管上皮极性丧失和轻度炎症,且MOC31在胆管上皮和肝细胞中阴性;对照组MOC31阳性。提示肝病理难以与合并症区分,但缺乏胆管反应可能为特征,且肝脏可用于MOC31诊断。
要点
- CTE肝活检MOC31在胆管上皮和肝细胞中阴性,对照组阳性
- CTE肝组织缺乏增殖性胆管反应,而其他原因PN对照均有
- 肝脏可作为CTE诊断的MOC31免疫组化适用组织
核心结论
- CTE肝病理难以与包括PN效应在内的合并症区分,但缺乏胆管反应可能为特征。
- 对照组胆管上皮和1带肝细胞MOC31阳性提示这些肝分区易受EpCAM缺陷影响。
- 肝脏是适用于MOC31免疫组化诊断CTE的组织。
研究设计与样本
- 研究识别有肝活检的CTE患者并回顾临床病理资料,包括MOC31免疫组化。
- 3例CTE患者共4次肝穿刺活检,年龄分别为1、5、7、16岁。
- 2次活检用于肠移植前评估,2次(同一患者)用于慢性丙型肝炎治疗前评估,所有患者均接受肠外营养(PN)。
主要发现
- 所有CTE肝标本显示胆管上皮极性丧失和轻度门管区及小叶炎症。
- 仅丙型肝炎患者显示纤维化;各1例出现小叶中性粒细胞微脓肿和大泡性脂肪变。
- CTE患者缺乏增殖性胆管反应,而其他原因PN的对照均有。
- CTE患者胆管上皮和肝细胞MOC31均阴性;对照显示一致的强膜性胆管上皮染色和斑片状膜性门管区周围肝细胞染色。
关键数值与推荐
- MOC31免疫组化:CTE患者胆管上皮和肝细胞阴性,对照胆管上皮强膜性、门管区周围肝细胞斑片状膜性阳性。
临床怎么用
- 肝活检组织可用于MOC31免疫组化辅助诊断CTE。
- 评估CTE肝病理时需结合PN等合并症,缺乏胆管反应可能提示CTE。
局限性
- 样本量小(3例患者4次活检),部分活检为丙型肝炎等合并症评估。
- CTE肝病理与PN效应等合并症难以区分,缺乏胆管反应的特异性需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Congenital tufting enteropathy (CTE) is a rare heritable cause of intractable diarrhea due to EPCAM mutation. Pathologic findings include intestinal villous atrophy, tufted discohesive tear-drop-shaped epithelium, and a normal brush border. In affected patients, absent intestinal epithelial cell adhesion molecule (EpCAM) expression results in loss of MOC31 immunostaining. CTE liver pathology has not yet been described. We identified CTE patients with liver biopsies and reviewed clinicopathologic material including MOC31 immunohistochemistry. Three CTE patients had 4 liver core biopsies (at ages 1, 5, 7, and 16 y), 2 for preintestinal transplant evaluation, and 2 (from a single patient) for pretreatment assessment of chronic hepatitis C; all had received parenteral nutrition (PN). All samples showed loss of biliary epithelial polarization and mild portal and lobular inflammation. Only the hepatitis C patient demonstrated fibrosis. One patient each had lobular neutrophilic microabscesses and macrovesicular steatosis. Proliferative ductular reactions were absent in CTE patients but present in all controls on PN for other reasons. MOC31 was absent in biliary epithelium and hepatocytes of all CTE patients; controls showed consistent strong membranous biliary epithelial and patchy membranous periportal hepatocyte staining. Our data show that, histologically, hepatopathy in CTE can be difficult to separate from comorbid disease including PN effect; however, the absent ductular reaction may be characteristic. MOC31 localization in the biliary epithelium and zone 1 hepatocytes of controls suggests these compartments of the liver might be most susceptible to effects of EpCAM deficiency. In addition, we validate the liver as suitable tissue for CTE diagnosis using MOC31 immunohistochemistry.
引用
- Chen S, Goldsmith JD, Fawaz R, et al. Liver Pathology, Including MOC31 Immunohistochemistry, in Congenital Tufting Enteropathy. Am J Surg Pathol. 2021. PMID: 33756496. doi:10.1097/PAS.0000000000001710
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。